The pharmacodynamic properties of repeated injections of atracurium were studied in twentytwo patients. A control group received narcotic-based anaesthesia while another group received the same narcotic-based anaesthesia subsequently modified by the addition of 0.5% isoflurane. The twitch response of the adductor pollicis muscle was recorded after train-off our (TOF) stimulation of the ulnar nerve at the wrist. Duration of effect and recovery time were measured. A bolus dose of atracurium (0.5 mg/kg b. w.) was given for tracheal intubation and maintenance doses of 0.2 mg/kg b. w. were given during anaesthesia at a TOF ratio of 0.25. Mean duration of anaesthesia was 7.5 hours (range 3-19). In the control group mean duration of effect and mean recovery time remained unchanged (six doses studied). A noteworthy interindividual variation was found. In the isoflurane group mean duration of effect increased from 36.1 (SD 6.3) minutes to 42.2 (SD 8.1) minutes (P < 0.05) following the addition ofisoflurane.
- 4 Sokoll and co-workers 5 noted, however, that when maintenance doses of atracurium were administered repeatedly, a neuromuscular blockade was created that was faster in onset and more profound than that following the initial dose. These findings could indicate altered pharmacodynamic properties of atracurium when given intermittently during prolonged anaesthesia. A low end-tidal concentration of isoflurane is frequently administered in combination with narcotic-based anaesthesia to stabilise and deepen the anaesthesia. Isoflurane is known to potentiate the effects of non-depolarising neuromuscular blocking agents. 6 -8 During isoflurane anaesthesia the amount of muscle relaxant required is thus less than when an intravenous anaesthetic technique is used. 9 The aim of this investigation was to study the duration of effect and recovery time following repetitive administration of atracurium during prolonged anaesthesia and to evaluate the influence on the duration of effect and recovery time from the addition of 0.5% isoflurane (end-tidal concentration) to narcotic-based anaesthesia.
METHODS Twenty-two patients (ASA 1-11) scheduled for reconstructive middle-ear surgery or translabyrinthine extirpation of acoustic neurinomas were studied. Ten patients (six men, four women, 29-75 years) received narcotic-based anaesthesia without addition of isoflurane (control group). Twelve patients (six men, six women, 16-69 years) received narcotic-based anaesthesia with the subsequent addition of 0.5% isoflurane (endtidal concentration, isoflurane group). The mean body weight was 67 (SD 11) and 69 (SD 11) kilograms, respectively. Informed verbal consent was obtained from all patients and the study was approved by the Local Ethics Committee.
All patients were premedicated with intramuscular oxicodone and scopolamine in doses according to body weight. Anaesthesia was induced with droperidol 0.2-0.4 mg/kg and fentanyl 4-7 mcglkg. The trachea was intubated after a bolus dose ofatracurium (0.5 mg/kg). During surgery maintenance doses of atracurium (0.2 mg/kg) were given when the train-of-four (TOF) ratio had reached 0.25. The patients were ventilated with a 35% 02 in N 20 using a Servo ventilator 900 B (Siemens-Elema, Sweden, non-rebreathing system). Ventilation was adjusted to maintain an endtidal C02 concentration of approximately 4 kPa (Normocap, Datex, Finland). Increments of fentanyl were given as required to maintain stable anaesthesia. In the isoflurane group the neuromuscular blockade was allowed to stabilise over three maintenance doses of atracurium. Isoflurane was then added from a Servo vaporiser (Siemens-Elema, Sweden). The vaporiser setting was adjusted to result in a steady end-tidal isoflurane concentration of 0.5% (Normae, Datex, Finland) corresponding approximately to 1.0 MAC in nitrous oxide-oxygen. 9 Steady-state end-tidal concentration was attained in 10-15 minutes. Supramaximal stimulation (square wave impulses, 0.2 ms duration) was delivered to the ulnar nerve at the wrist via skin electrodes using a Myotest stimulator (Biometer, Denmark). One Hz single twitch and TOF stimulation (2 Hz for 2 seconds every ten seconds) was applied with a preload of 0. from end of injection of the bolus dose to 100% depression of twitch height at 1 Hz single twitch stimulation; DUR-BOL-25 = duration of effect (minutes) of the bolus dose used for endotracheal intubation measured from the end of injection to recovery to a TOF ratio of 0.25; DUR-25 = duration of effect (minutes) of the maintenance doses given at a TOF ratio of 0.25 until a TOF ratio of 0.25 was reached again; Recovery-l 0-25 = time (seconds) for recovery from a TOF ratio of 0.1 0 to 0.25. To evaluate the influence of isoflurane (isoflurane group), DUR-25 and Recovery-10-25 were compared on three separate occasions corresponding to the following maintenance doses: (i) the maintenance dose immediately before adding isoflurane; (ii) the subsequent dose of atracurium following addition of isoflurane; (iii) the maintenance dose given after approximately one and a half hours of administration of isoflurane. In addition, skin temperature and systolic blood pressure were compared on these three occasions. Perioperatively a balanced glucosesaline solution was given IV (Rehydrex, Pharmacia, Sweden) at a rate of 5 mllkg bodyweight per hour. Skin temperature was continuously measured over the adductor pollicis muscle with an isolated temperature probe (Electric thermometer, type TE 3, Ellab Ltd., Denmark). Heart rate, blood pressure and ECG were likewise monitored throughout the procedure.
STATISTICS
For statistical evaluation the paired Student's t-test was used. The results are presented as mean with SD in parentheses. P < 0.05 was considered to be statistically signifi can t.
RESULTS

Control group
Mean duration of anaesthesia was 7.6 hours (range 3.1-19.0). Onset time was 95 seconds (SD 31, range 60-150) and mean DUR-BOL-25 was 57 minutes (SD 7, range 50-73). When comparing mean DUR-25 there were only small variations even after six maintenance doses (n.s.) (see Figure 1 ). There was, however, a considerable variation in duration of effect between individuals (see Table I ).
Isoflurane group
Mean duration of anaesthesia was 7.3 hours (range 4.0-13.8). Onset time was 90 seconds (SD 25, range 50-150) and mean DUR-BOL-25 was 52 minutes (SD 8, range 41-71). Before isoflurane was added (i) the mean DUR-25 was 36.1 minutes (SD 6.3, range 26-46). Following addition of isoflurane (ii) I  35  38  260  270  270  2  56  310  300  3  43  320  320  4  38  37  270  280  280  5  34  35  170  180  230  6  35  33  250  250  250  7  33  36  300  300  280  8  33  34  220  250  230  9  44  54  350  350 Table 3 ). Mean Recovery-IO-25 remained unchanged (see Table 2 ). Skin temperature over the adductor pollicis muscle decreased approximately 1°C (range 0-1.2°C) and systolic blood pressure following addition of isoflurane remained stable with a maximum fall of 5 mmHg. Heart rate showed only minor variations and no arrhythmias were observed.
DISCUSSION
In the control group there was a marked variation in duration of effect and recovery time between individuals. Each patient, however, had a near-constant interval between maintenance doses with only minimal variation in duration of effect even after six maintenance doses of atracurium. In addition, there was no alteration in recovery time following the larger bolus dose of atracurium for intubation (0.5 mg/kg b.w.) and the smaller third and sixth maintenance dose (0.2 mg/kg b.w.). Hence, recovery time was stable in the dose-range of 0.2-0.5 mg/kg body weight of atracurium. In contrast to the altered neuromuscular blockade after repetitive use, suggested by Sokoll et al., 5 our results indicate that the pharmacodynamic properties remained unchanged after repeated administration of atracurium of 0.2 mg/kg body weight during narcotic-based anaesthesia.
Combinations of volatile anaesthetic agents (with MAC-values of isoflurane in the range 1.2-2.2) and nitrous oxide-oxygen significantly potentiate neuromuscular blockade caused by non-depolarising muscle relaxants. 1,5-9,1 1- 13 Our results indicate that the combination of an end-tidal concentration of 0.5% isoflurane and a narcotic-based intravenous anaesthetic moderately increases the duration of effect of repeated doses of atracurium. This prolongation of effect was observed following the first maintenance dose Duration of effect (DUR-25, minutes), recovery time (Recovery-1O-25, seconds), systolic blood pressure (mmHg) and hand skin temperature (Oe) in twelve patients receiving a 0.5% end-tidal concentration of isoflurane in addition to narcoticbased anaesthesia. Measurements were made before addition of isoflurane (i), on the subsequent maintenance dose following addition of isoflurane (ii) 
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given after the addition of isoflurane. Stanski and co-workers have demonstrated a timedependent increase in sensitivity to d-tubocurarine during enflurane anaesthesia. 14 In order to avoid any timerelated differences, all patients were therefore evaluated after the first maintenance dose of atracurium following the addition of isoflurane and again following a dose given after an almost equally long exposure to isoflurane. A tendency towards a further ( prolongation of duration of effect was demonstrated, when isoflurane had been administered for approximately one and a half hours. There was a noteworthy variation in duration of effect between the patients before as well as after the addition of isoflurane. These findings confirm the variation previously described by Stirt and co-workers,12 but we have also shown that there is a great inter-individual variation in the duration of effect of atracurium following 260  250  260  2  33  36  37  180  220  200  3  38  43  47  260  260  260  4  35  37  38  300  280  5  30  30  34  260  260  240  6  26  28  30  150  190  160  7  42  48  52  190  200  220  8  27  29  33  260  210  230  9  36  43  44  250  260  220  10  36  37  39  150  170  170  11  42  46  53  360  370  380  12  46  54  53  230  250 the addition of isoflurane. The influence on the duration of effect of atracurium from isoflurane in each patient therefore seems unpredictable. To meet individual requirements for atracurium, neuromuscular monitoring is thus highly advisable. As opposed to the influence on duration of effect, recovery time was not affected by the addition of isoflurane. Each patient showed a stable recovery time even after isoflurane had been administered for approximately one and a half hours. This was comparable to the control group. Isoflurane may affect the cardiovascular system: 9 ,11 depression of cardiac output, alterations in the peripheral circulation as well as changes in skin and body temperature are reported. These factors are known to interfere with neuromuscular transmission. 15 To avoid the influence of physiological factors in this study, otherwise healthy patients were investigated under standardised conditions, such as a stable peripheral circulation indicated by an unchanged skin temperature and controlled and monitored end-tidal C02 concentration and FI02. In addition, blood loss was minimal, plasma electrolytes were normal and none of the patients was given any drug known to affect neuromuscular transmission.
We conclude that during a narcotic-based anaesthetic, no cumulative effect could be demonstrated after six maintenance doses of 0.2 mg/kg of atracurium. Addition of an endtidal concentration of 0.5% isoflurane to a narcotic-based anaesthetic moderately prolonged the duration of effect but not the recovery time from atracurium.
